Analysts expect Immunome Inc. to report revenue of 171,826.26 for Q3 26, against a range of 157,804.55 to 185,847.97. The most recent reported quarter, Q2 26, came in at 0.00, a 100.0% miss against the 157,383.98 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 2.91 M | 2.74 M | 2.93 M | 4.01 M | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 2.38 M | 3.49 M | 800,099.79 | 908,096.91 | 897,584.92 | 881,088.10 | 223,014.64 | 162,657.45 | 185,847.97 | 195,451.37 | 3.15 M | 7.91 M | 7.51 M | 8.63 M | 44.60 M | 51.08 M | ||||||||||
| Low Estimate | 2.04 M | 2.97 M | 681,334.67 | 826,829.49 | 772,847.08 | 816,666.80 | 205,569.96 | 152,110.51 | 157,804.55 | 176,450.53 | 2.77 M | 6.85 M | 6.18 M | 7.29 M | 41.68 M | 43.32 M | ||||||||||
| Consensus Estimate | 2.21 M | 3.23 M | 740,717.23 | 867,463.20 | 835,216.00 | 848,877.45 | 214,292.30 | 157,383.98 | 171,826.26 | 185,950.95 | 2.96 M | 7.38 M | 6.84 M | 7.96 M | 43.14 M | 47.20 M |
Analysts expect Immunome Inc. to report earnings per share of -0.58 for Q3 26, against a range of -0.63 to -0.53. The most recent reported quarter, Q2 26, came in at -0.65, a 20.4% miss against the -0.54 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.78 | -1.11 | -0.52 | -0.50 | -0.65 | -0.76 | -0.48 | -0.65 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.52 | -0.56 | -0.57 | -0.47 | -0.50 | -0.51 | -0.49 | -0.52 | -0.53 | -0.53 | -0.63 | -0.63 | -0.63 | -0.56 | -0.31 | -0.34 | ||||||||||
| Low Estimate | -0.62 | -0.68 | -0.65 | -0.55 | -0.58 | -0.59 | -0.57 | -0.56 | -0.63 | -0.63 | -0.69 | -0.73 | -0.73 | -0.66 | -0.35 | -0.40 | ||||||||||
| Consensus Estimate | -0.57 | -0.62 | -0.61 | -0.51 | -0.54 | -0.55 | -0.53 | -0.54 | -0.58 | -0.58 | -0.66 | -0.68 | -0.68 | -0.61 | -0.33 | -0.37 |
Pull Wall Street consensus for Immunome Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=IMNM&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "IMNM", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=IMNM&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();